Mckesson Corporation
American company distributing pharmaceuticals.
Based in CA
AI Overview
With $1.7M in lobbying spend across 34 quarterly filings, Mckesson Corporation is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $250K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $250K |
| 2025 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Mckesson Corporation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
General Medicare/Medicaid Issues.
Issues as they related to opioid abuse policy.
General Medicare/Medicaid Issues.
Issues as they related to opioid abuse policy.
Medicare physician payment.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.